Vaccine Production

11 February 2021 |

All countries need vaccines but not all can produce them. Vaccine production is highly specialised, subject to comparative advantages, and concentrated in few countries, making trade a vital means to deploying vaccines broadly. Keeping markets open by reducing tariffs, streamlining trade-related processes at and behind the border while ensuring better co-ordination of logistical processes will be key to ensuring timely access to vaccines for all. This note discusses trade and trade policy considerations underpinning access to the final and intermediate goods needed to effectively produce, deliver and administer COVID-19 vaccines. It focuses on the international aspects of the vaccine supply chain, discussing the sourcing, production, distribution and need to expedite international border crossing and transportation (including in the context of the cold supply chain).

Read more at the file below.

RELATED FILES

ENTERPRISE GREECE
profile icon

Company Profile

READ MORE
dioikitiko simvoulio icon

Board of Directors

READ MORE
diktio sinergaton icon

Stakeholder Network

READ MORE
epikoinonia icon

Contact us

READ MORE

LOGIN